A dry powder inhaler containing fluticasone propionate and salmeterol or propoate

摘要

The present invention relates to a dry powder inhaler comprising a dry powdered medicament comprising fluticasone propionate, salmeterol and poite and a lactose carrier, wherein the delivery capacity of fluticasone propionate per operation is less than 100 占 퐂; The dose should provide to a dry powder inhaler providing a baseline FEV ₁ adjusted in a patient in less than 30 minutes after receiving the dose more than 150 mL. The method of treating a patient comprises the step of administering to the patient a dry powder medicament comprising fluticasone propionate, salmeterol or aphate and a lactose carrier; The delivery capacity of fluticasone propionate per operation is less than 100 占 퐂; The dose provides a baseline adjustment FEV ₁ in the patient in excess of 150 mL within 30 minutes of receiving the dose.